Not recruiting
Latent autoimmune diabetes in adults
Not recruitingInvestigationalNo placebo
Study on Latent Autoimmune Diabetes in Adults (LADA) Patients: Evaluating Diabetes Status 3 Years After Treatment with Glutamate Decarboxylase 2
InvestigationalNo placebo
- Disease:Latent autoimmune diabetes in adults
- Substances:Glutamate Decarboxylase 2, Human, Recombinant
Countries:
Norway
Norway- Participants:18–64 years · 65+ years
- Substances:Glutamate Decarboxylase 2, Human, Recombinant
- Sponsor:Norwegian University Of Science And Technolology

